Baseline serum uric acid level is associated with progression-free survival, disease control rate, and safety in postoperative patients with colorectal cancer treated by FOLFOX, FOLFIRI, or XELOX.

Zhang, Xi; Chen, Qing-Hong; Yang, Ying; Lin, Jing-Xin; Li, Yan-Chun; Zhong, Tian-Yu; Chen, Jie; Wu, Si-Qi; Chen, Xiao-Hu; Zhou, Rui-Si; Lin, Jia-Man; Wang, Dong-Qing; He, Qiu-Xing; You, Yan-Ting; Zhou, Xing-Hong; Zuo, Qiang; Liu, Yan-Yan; Cheng, Jing-Ru; Wu, Yi-Fen; Zhao, Xiao-Shan

Zhang, Xi; Chen, Qing-Hong; Yang, Ying; Lin, Jing-Xin; Li, Yan-Chun; Zhong, Tian-Yu; Chen, Jie; Wu, Si-Qi; Chen, Xiao-Hu; Zhou, Rui-Si; Lin, Jia-Man; Wang, Dong-Qing; He, Qiu-Xing; You, Yan-Ting; Zhou, Xing-Hong; Zuo, Qiang; Liu, Yan-Yan; Cheng, Jing-Ru; Wu, Yi-Fen; Zhao, Xiao-Shan.

Afiliação

Zhang X; Syndrome Laboratory of Integrated Chinese and Western Medicine, School of Chinese Medicine, Southern Medical University, Guangzhou, China.
Chen QH; Department of Oncology, Affiliated Dongguan People's Hospital, Southern Medical University, Dongguan, China.
Yang Y; Syndrome Laboratory of Integrated Chinese and Western Medicine, School of Chinese Medicine, Southern Medical University, Guangzhou, China.
Lin JX; Syndrome Laboratory of Integrated Chinese and Western Medicine, School of Chinese Medicine, Southern Medical University, Guangzhou, China.
Li YC; Syndrome Laboratory of Integrated Chinese and Western Medicine, School of Chinese Medicine, Southern Medical University, Guangzhou, China.
Zhong TY; Department of Nephrology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Chen J; Syndrome Laboratory of Integrated Chinese and Western Medicine, School of Chinese Medicine, Southern Medical University, Guangzhou, China.
Wu SQ; Syndrome Laboratory of Integrated Chinese and Western Medicine, School of Chinese Medicine, Southern Medical University, Guangzhou, China.
Chen XH; Syndrome Laboratory of Integrated Chinese and Western Medicine, School of Chinese Medicine, Southern Medical University, Guangzhou, China.
Zhou RS; Syndrome Laboratory of Integrated Chinese and Western Medicine, School of Chinese Medicine, Southern Medical University, Guangzhou, China.
Lin JM; Syndrome Laboratory of Integrated Chinese and Western Medicine, School of Chinese Medicine, Southern Medical University, Guangzhou, China.
Wang DQ; Syndrome Laboratory of Integrated Chinese and Western Medicine, School of Chinese Medicine, Southern Medical University, Guangzhou, China.
He QX; Syndrome Laboratory of Integrated Chinese and Western Medicine, School of Chinese Medicine, Southern Medical University, Guangzhou, China.
You YT; Syndrome Laboratory of Integrated Chinese and Western Medicine, School of Chinese Medicine, Southern Medical University, Guangzhou, China.
Zhou XH; Syndrome Laboratory of Integrated Chinese and Western Medicine, School of Chinese Medicine, Southern Medical University, Guangzhou, China.
Zuo Q; Syndrome Laboratory of Integrated Chinese and Western Medicine, School of Chinese Medicine, Southern Medical University, Guangzhou, China.
Liu YY; Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Cheng JR; Syndrome Laboratory of Integrated Chinese and Western Medicine, School of Chinese Medicine, Southern Medical University, Guangzhou, China.
Wu YF; Department of Nephrology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Zhao XS; Department of Oncology, Affiliated Dongguan People's Hospital, Southern Medical University, Dongguan, China.

Front Oncol ; 12: 918088, 2022.

Article em En | MEDLINE | ID: mdl-35965512

Palavras-chave

colorectal cancer; disease control rate; prognosis; safety; uric acid

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google